HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...
A University of Iowa student’s research is exploring new hormone therapies for uterine cancer. Five new progestins have shown more promise in lab tests than current clinical drugs. Her research helped ...
The global Gynecological Devices market is expanding, supported by the higher prevalence of diseases like PCOS, uterine fibroids and cervical cancer, continued innovation in minimally invasive ...
Uterine fibroids—common, often missed and frequently painful growths made of muscle and other tissue inside the uterus—may dramatically raise the risk of heart disease, a new paper finds. In a study ...
In the fast-growing diagnostics testing market, Hologic HOLX and Quest Diagnostics DGX stand out as two prominent players, each with its own niche. Hologic focuses on women’s health, providing a wide ...
Stage 2 endometrial cancer spreads to the cervical stroma but remains within the uterus and cervix, requiring precise staging and diagnosis. Treatment typically involves surgery, possibly a radical ...
Painful experience has taught Erika Moore that benign doesn’t always mean harmless. Moore, a biomedical engineer at the University of Maryland in College Park, lives with noncancerous tumors in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results